Email updates

Keep up to date with the latest news and content from AACI and BioMed Central.

This article is part of the supplement: Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2012

Open Access Open Badges Meeting abstract

Anaphylaxis to Polysporin® ointment in a pediatric patient

Anna-Claire Coleman1*, Sandeep Kapur123, Wade Watson12 and Lori Connors34

Author Affiliations

1 Department of Pediatrics, Dalhousie University, Halifax NS, Canada

2 Division of Allergy, IWK Health Centre, Halifax NS, Canada

3 Halifax Allergy and Asthma Associates, Halifax NS, Canada

4 Department of Internal Medicine, Dalhousie University, Halifax NS, Canada

For all author emails, please log on.

Allergy, Asthma & Clinical Immunology 2012, 8(Suppl 1):A13  doi:10.1186/1710-1492-8-S1-A13

The electronic version of this article is the complete one and can be found online at:

Published:2 November 2012

© 2012 Coleman et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Topical antibiotics are widely used over the counter preparations to treat and prevent common skin infections. Severe allergic reactions to these preparations are rare. We report a case of anaphylaxis after topical application of Polysporin® ointment.

Case report

A 13 year old male rubbed a white eraser against the dorsum of his hand at school and the skin became abraded with some open areas of broken skin. He applied Polysporin® ointment (polymyxin B sulfate and bacitracin) to the area after he arrived home. Within 15 minutes he developed urticaria on his back, legs and arms. His eyes became very itchy and he developed marked angioedema of his eyelids with urticaria around his eyes. He developed difficulty breathing and described a tight feeling in his chest. He took diphenhydramine and salbutamol via MDI. He did not go to the Emergency Department. His symptoms gradually resolved after approximately two hours. Previous use of Polysporin® in the past did not cause any difficulties. Epicutaneous testing was positive to a 1 in 10 dilution of Polysporin® ointment. Testing was negative to latex. Further testing to the specific components, polymyxin B sulfate and bacitracin is pending.


This patient’s history and skin test results are in keeping with an IgE-mediated reaction to this Polysporin® preparation. Although rare, severe reactions can occur. Health care professionals should be reminded to inquire about previous reactions to topical antibiotics before suggesting their use.